S. Bozkurt Et Al. , "Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality," TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.1, pp.62-63, 2019
Bozkurt, S. Et Al. 2019. Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality. TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.1 , 62-63.
Bozkurt, S., OKAY, M., & Haznedaroglu, I., (2019). Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality. TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.1, 62-63.
Bozkurt, SÜREYYA, MÜFİDE OKAY, And Ibrahim Haznedaroglu. "Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality," TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.1, 62-63, 2019
Bozkurt, SÜREYYA Et Al. "Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality." TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.1, pp.62-63, 2019
Bozkurt, S. OKAY, M. And Haznedaroglu, I. (2019) . "Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality." TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.1, pp.62-63.
@article{article, author={SÜREYYA BOZKURT Et Al. }, title={Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2019, pages={62-63} }